Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

CR Frei, NP Wiederhold… - Journal of antimicrobial …, 2008 - academic.oup.com
Objectives This study describes a comprehensive programme designed to develop
pharmacokinetic–pharmacodynamic (PK–PD) breakpoints for numerous antimicrobial …
被引用次数：144 相关文章
[HTML] nih.gov

[HTML][HTML] Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

CR Frei, NP Wiederhold, DS Burgess - The Journal of …, 2008 - ncbi.nlm.nih.gov
Objectives This study describes a comprehensive programme designed to develop
pharmacokinetic–pharmacodynamic (PK–PD) breakpoints for numerous antimicrobial …

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation

CR Frei, NP Wiederhold… - Journal of Antimicrobial …, 2008 - scholars.uthscsa.edu
Objectives: This study describes a comprehensive programme designed to develop
pharmacokinetic-pharmacodynamic (PK-PD) breakpoints for numerous antimicrobial …
[PDF] researchgate.net

[PDF][PDF] Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

CR Frei, NP Wiederhold, DS Burgess - J Antimicrob Chemother, 2008 - researchgate.net
Objectives—This study describes a comprehensive programme designed to develop
pharmacokinetic–pharmacodynamic (PK–PD) breakpoints for numerous antimicrobial …

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation

CR Frei, NP Wiederhold, DS Burgess - Journal of Antimicrobial …, 2008 - elibrary.ru
Objectives This study describes a comprehensive programme designed to develop
pharmacokinetic–pharmacodynamic (PK–PD) breakpoints for numerous antimicrobial …
[PDF] psu.edu

[PDF][PDF] Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

CR Frei, NP Wiederhold, DS Burgess - Journal of Antimicrobial …, 2008 - Citeseer
Objectives: This study describes a comprehensive programme designed to develop
pharmacokinetic–pharmacodynamic (PK–PD) breakpoints for numerous antimicrobial …

[引用][C] Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

CR Frei, NP Wiederhold, DS Burgess - Journal of Antimicrobial …, 2008 - cir.nii.ac.jp
Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic
models with Monte Carlo simulation | CiNii Research CiNii 国立情報学研究所 学術情報 …

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation.

CR Frei, NP Wiederhold… - Journal of Antimicrobial …, 2008 - search.ebscohost.com
Objectives This study describes a comprehensive programme designed to develop
pharmacokinetic–pharmacodynamic (PK–PD) breakpoints for numerous antimicrobial …

Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation.

CR Frei, NP Wiederhold, DS Burgess - The Journal of Antimicrobial …, 2008 - europepmc.org
Objectives This study describes a comprehensive programme designed to develop
pharmacokinetic-pharmacodynamic (PK-PD) breakpoints for numerous antimicrobial …

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation.

CR Frei, NP Wiederhold, DS Burgess - 2008 - cabidigitallibrary.org
Objectives: This study describes a comprehensive programme designed to develop
pharmacokinetic-pharmacodynamic (PK-PD) breakpoints for numerous antimicrobial …